EligibleTrials

Refusal of Sentinel Lymph Node Biopsy in Patients With Luminal A Subtype Early Breast Cancer

Recruiting · NCT07579286 · Interventional (participants receive a specific treatment) · Lead sponsor: N.N. Petrov National Medical Research Center of Oncology

View the official record on ClinicalTrials.gov →
Breast cancer

Interventions studied

Breast resection with sentinel lymph node biopsybreast resection

What this trial is about

Sentinel lymph node biopsy (SLNB) is the standard of axillary lymph node surgical staging in patients with early breast cancer. The main goal of the study is to abandon axillary surgery in patients over 59 years old with early, luminal A, clinical lymph node negative breast cancer.

Who can take part

Age range
60 Years and older
Sex
Female
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

1 location listed.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.